Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) FCF Margin (2016 - 2017)

Historic FCF Margin for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to 63.86%.

  • Bone Biologics' FCF Margin changed N/A to 63.86% in Q4 2017 from the same period last year, while for Dec 2017 it was 75.28%, marking a year-over-year decrease of 6346700.0%. This contributed to the annual value of 152.6% for FY2021, which is 1098200.0% up from last year.
  • According to the latest figures from Q4 2017, Bone Biologics' FCF Margin is 63.86%.
  • Over the past 5 years, Bone Biologics' FCF Margin peaked at 814.94% during Q1 2016, and registered a low of 45.06% during Q3 2017.